Re: Oishi et al.: LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy (Ophthalmology 2014;121:1151-2) reply

被引：0
|
作者：
Oishi, Akio [1 ]
Oh, Hideyasu [2 ]
Mandai, Michiko [1 ]
Honda, Shigeru [3 ]
Miyamoto, Noriko [1 ]
机构：
[1] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan
[2] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan
[3] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan
来源：
OPHTHALMOLOGY | 2015年 / 122卷 / 01期
关键词：
MONOTHERAPY;
D O I：
10.1016/j.ophtha.2014.07.006
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E6 / E7
页数：3
相关论文
共 17 条
  • [1] Re: Oishi et al.: LAPTOP study: a 24-month trial of verteporfin versus ranibizumab for polypoidal choroidal vasculopathy (Ophthalmology 2014;121:1151-2)
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    OPHTHALMOLOGY, 2015, 122 (01) : E5 - E6
  • [2] LAPTOP Study: A 24-Month Trial of Verteporfin Versus Ranibizumab for Polypoidal Choroidal Vasculopathy
    Oishi, Akio
    Miyamoto, Noriko
    Mandai, Michiko
    Honda, Shigeru
    Matsuoka, Toshiyuki
    Oh, Hideyasu
    Kita, Mihori
    Nagai, Tomoko
    Bessho, Nobuhiro
    Uenishi, Mamoru
    Kurimoto, Yasuo
    Negi, Akira
    OPHTHALMOLOGY, 2014, 121 (05) : 1151 - 1152
  • [3] Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: 24-month results from the EVEREST II study
    Koh, Adrian H. C.
    Parikh, Soumil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [4] Re: Farias et al.: Choroidal thickness in patients with diabetes and microalbuminuria (Ophthalmology 2014;121:2071-3) Reply
    Farias, Lucas B.
    Lavinsky, Daniel
    Lavinsky, Jaco
    Canani, Luis H.
    OPHTHALMOLOGY, 2015, 122 (07) : E43 - E43
  • [5] Re: Coster et al.: A comparison of lamellar and penetrating keratoplasty outcomes: a registry study (Ophthalmology 2014;121:979-87) Reply
    Coster, Douglas J.
    Keane, Miriam C.
    Williams, Keryn A.
    OPHTHALMOLOGY, 2014, 121 (10) : E59 - E60
  • [6] Re: Abell et al.: Anterior Capsulotomy Integrity after Femtosecond Laser-Assisted Cataract Surgery (Ophthalmology 2014; 121: 17-24) Reply
    Abell, Robin G.
    Davies, Peter E. J.
    Allen, Penelope L.
    Vote, Brendan J.
    OPHTHALMOLOGY, 2014, 121 (07) : E36 - E37
  • [7] Re: Bakri et al.: Intraocular pressure in eyes receiving monthly ranibizumab in 2 pivotal age-related macular degeneration clinical trials (Ophthalmology 2014;121:1102-8) Reply
    Bakri, Sophie J.
    Moshfeghi, Darius M.
    Francom, Steve
    Rundle, Amy Chen
    Reshef, Daniel S.
    Lee, Paul P.
    Schaeffer, Carol
    Rubio, Roman G.
    Lai, Phillip
    OPHTHALMOLOGY, 2015, 122 (03) : E19 - E19
  • [8] Re: Nanji et al.: Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications (Ophthalmology 2014; 121: 994-1000) Reply
    Nanji, Afshan A.
    Galor, Anat
    Karp, Carol L.
    OPHTHALMOLOGY, 2014, 121 (12) : E66 - E67
  • [9] Re: Jonas et al.: Cognitive function and subfoveal choroidal thickness: The Beijing Eye Study (Ophthalmology 2016;123:220-2) REPLY
    Jonas, Jost B.
    Wang, Ya Xing
    Bin Wei, Wen
    Zhu, Li Ping
    Shao, Lei
    Xu, Liang
    OPHTHALMOLOGY, 2016, 123 (11) : E64 - E65
  • [10] Re: Abell et al.: Cost-effectiveness of femtosecond laser-assisted cataract surgery versus phacoemulsification cataract surgery (Ophthalmology 2014;121:10-6) Reply
    Ewe, Shaun Y. P.
    Abell, Robin G.
    Vote, Brendan J.
    OPHTHALMOLOGY, 2014, 121 (10) : E54 - E55
12